相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ferroptosis is a type of autophagy-dependent cell death
Borong Zhou et al.
SEMINARS IN CANCER BIOLOGY (2020)
Ibuprofen induces ferroptosis of glioblastoma cells via downregulation of nuclear factor erythroid 2-related factor 2 signaling pathway
Xingchun Gao et al.
ANTI-CANCER DRUGS (2020)
ACSL4 suppresses glioma cells proliferation via activating ferroptosis
Jing Cheng et al.
ONCOLOGY REPORTS (2020)
Lipid Peroxidation Plays an Important Role in Chemotherapeutic Effects of Temozolomide and the Development of Therapy Resistance in Human Glioblastoma
Wei Wu et al.
TRANSLATIONAL ONCOLOGY (2020)
AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis
Tzu-Chi Chen et al.
REDOX BIOLOGY (2020)
Transferrin Receptor Is a Specific Ferroptosis Marker
Huizhong Feng et al.
CELL REPORTS (2020)
Autophagy-Dependent Ferroptosis: Machinery and Regulation
Jiao Liu et al.
CELL CHEMICAL BIOLOGY (2020)
Ferroptosis, a new form of cell death: opportunities and challenges in cancer
Yanhua Mou et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Clockophagy is a novel selective autophagy process favoring ferroptosis
Minghua Yang et al.
SCIENCE ADVANCES (2019)
Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells
Yibing Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
A Novel DNA Methylation-Based Signature Can Predict the Responses of MGMT Promoter Unmethylated Glioblastomas to Temozolomide
Rui-Chao Chai et al.
FRONTIERS IN GENETICS (2019)
FSP1 is a glutathione-independent ferroptosis suppressor
Sebastian Doll et al.
NATURE (2019)
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Kirill Bersuker et al.
NATURE (2019)
Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis
Lian-Jiu Su et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma
Alessia Lo Dico et al.
CELLS (2019)
Iron Metabolism in Cancer
Yafang Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
Jose Pedro Friedmann Angeli et al.
NATURE REVIEWS CANCER (2019)
Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis
Zhongling Zhu et al.
JOURNAL OF NEUROCHEMISTRY (2018)
Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities
Byung-Jin Jung et al.
BIOMOLECULES & THERAPEUTICS (2018)
miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma
Yaomin Li et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Ferroptosis-Induced Endoplasmic Reticulum Stress: Cross-talk between Ferroptosis and Apoptosis
Young-Sun Lee et al.
MOLECULAR CANCER RESEARCH (2018)
Scavenging of reactive oxygen and nitrogen species with nanomaterials
Carolina A. Ferreira et al.
NANO RESEARCH (2018)
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas
Hideaki Abe et al.
NEUROLOGIA MEDICO-CHIRURGICA (2018)
p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells
Amy Tarangelo et al.
CELL REPORTS (2018)
Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing
Zahra Shajani-Yi et al.
NEOPLASIA (2018)
Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
Shabierjiang Jiapaer et al.
NEUROLOGIA MEDICO-CHIRURGICA (2018)
Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis
Mariachiara Buccarelli et al.
CELL DEATH & DISEASE (2018)
The Roles of NRF2 in Modulating Cellular Iron Homeostasis
Michael John Kerins et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer
Xinbing Sui et al.
FRONTIERS IN PHARMACOLOGY (2018)
Switching Apoptosis to Ferroptosis: Metal-Organic Network for High-Efficiency Anticancer Therapy
Di-Wei Zheng et al.
NANO LETTERS (2017)
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Sebastian Doll et al.
NATURE CHEMICAL BIOLOGY (2017)
Characterization of Ferroptosis in Murine Models of Hemochromatosis
Hao Wang et al.
HEPATOLOGY (2017)
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Matthew J. Hangauer et al.
NATURE (2017)
ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner
D. Chen et al.
ONCOGENE (2017)
Gpx 4 is involved in the proliferation, migration and apoptosis of glioma cells
Hongyu Zhao et al.
PATHOLOGY RESEARCH AND PRACTICE (2017)
FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide
Li Zhang et al.
PHARMACOLOGICAL REPORTS (2017)
All-trans retinoic acid enhances temozolomide-induced autophagy in human glioma cells U251 via targeting Keapl/Nrf2/ARE signaling pathway
Lin Shi et al.
ONCOLOGY LETTERS (2017)
The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas
Daishi Chen et al.
ONCOTARGET (2017)
Molecular crosstalk between ferroptosis and apoptosis: emerging role of ER stress-induced p53-independent PUMA expression
Se Hoon Hong et al.
ONCOTARGET (2017)
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
Z. Fan et al.
ONCOGENESIS (2017)
Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis
Jong-Lyel Roh et al.
REDOX BIOLOGY (2017)
Iron metabolism and drug resistance in cancer
Hasan Huseyin Kazan et al.
BIOMETALS (2017)
Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
Xiaofang Sun et al.
HEPATOLOGY (2016)
Autophagy promotes ferroptosis by degradation of ferritin
Wen Hou et al.
AUTOPHAGY (2016)
Identification of ACSL4 as a biomarker and contributor of ferroptosis
Hua Yuan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
An essential role for functional lysosomes in ferroptosis of cancer cells
Seiji Torii et al.
BIOCHEMICAL JOURNAL (2016)
Deferiprone Enhances Temozolomide Cytotoxicity in Glioma Cells
George A. Alexiou et al.
CANCER INVESTIGATION (2016)
The Challenge of Developing Autophagy Inhibition as a Therapeutic Strategy
David A. Gewirtz
CANCER RESEARCH (2016)
Ferroptosis: process and function
Y. Xie et al.
CELL DEATH AND DIFFERENTIATION (2016)
Targeting autophagy to sensitive glioma to temozolomide treatment
Yuanliang Yan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance
Monika D. Polewski et al.
MOLECULAR CANCER RESEARCH (2016)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2016)
Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis
Wan Seok Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis
Tina Sehm et al.
ONCOTARGET (2016)
NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells
Clarissa Ribeiro Reily Rocha et al.
ONCOTARGET (2016)
Critical appraisal of temozolomide formulations in the treatment of primary brain tumors: patient considerations
Margarita Garcia-Martin et al.
Cancer Management and Research (2016)
Temozolomide resistance in glioblastoma multiforme
Sang Y. Lee
GENES & DISEASES (2016)
Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells
David L. Schonberg et al.
CANCER CELL (2015)
The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells
Seung Woo Lee et al.
CANCER LETTERS (2015)
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma
Barbara Banelli et al.
CELL CYCLE (2015)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
Transferrin receptors and glioblastoma multiforme: Current findings and potential for treatment
Brittany Voth et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Ferroptosis as a p53-mediated activity during tumour suppression
Le Jiang et al.
NATURE (2015)
Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function
Liangyu Chen et al.
ONCOLOGY REPORTS (2015)
Iron metabolism: a double-edged sword in the resistance of glioblastoma to therapies
Claire Legendre et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Effect of temozolomide on livin and caspase-3 in U251 glioma stem cells
Genhua Li et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Gain of Function of Mutant TP53 in Glioblastoma: Prognosis and Response to Temozolomide
Xiang Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
p62/SQSTM1 is involved in cisplatin resistance in human ovarian cancer cells via the Keap1-Nrf2-ARE system
Meihui Xia et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Nrf2- and ATF4-Dependent Upregulation of xCT Modulates the Sensitivity of T24 Bladder Carcinoma Cells to Proteasome Inhibition
Peng Ye et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT/mTOR signaling
Haitao Yin et al.
ONCOLOGY REPORTS (2014)
Targeting the NF-E2-related factor 2 pathway: A novel strategy for glioblastoma (Review)
Jianhong Zhu et al.
ONCOLOGY REPORTS (2014)
Bak and Mcl-1 are essential for Temozolomide induced cell death in human glioma
Catherine Gratas et al.
ONCOTARGET (2014)
Emerging Therapies for Glioblastoma
Alissa A. Thomas et al.
JAMA NEUROLOGY (2014)
Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA Damage
Anna V. Knizhnik et al.
PLOS ONE (2013)
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
X. Sui et al.
CELL DEATH & DISEASE (2013)
Tumor suppressor WWOX and p53 alterations and drug resistance in glioblastomas
Ming-Fu Chiang et al.
FRONTIERS IN ONCOLOGY (2013)
The intracellular trafficking pathway of transferrin
Kristine M. Mayle et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma
Michael D. Blough et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide
K. A. van Nifterik et al.
BRITISH JOURNAL OF CANCER (2010)
Transferrin Receptor 2 Is Frequently and Highly Expressed in Glioblastomas
Alessia Calzolari et al.
TRANSLATIONAL ONCOLOGY (2010)
Advances in the Treatment of Malignant Gliomas
Mustafa Khasraw et al.
CURRENT ONCOLOGY REPORTS (2010)
Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator
Yan Jiao et al.
BLOOD (2009)
MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma
Andrew M. Donson et al.
PEDIATRIC BLOOD & CANCER (2007)
Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O-6-methylguanine
W. P. Roos et al.
ONCOGENE (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Iron chelation in the biological activity of curcumin
Y Jiao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells
T Kanzawa et al.
CELL DEATH AND DIFFERENTIATION (2004)
Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide
T Kanzawa et al.
JOURNAL OF NEUROSURGERY (2003)
分享论文
